The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

The First International Symposium on Pheochromocytoma ... Localization studies should only follow reasonable clinical evidence of a tumor. Preoperative pharmacologic blockade of circulatory ...

Hallmark symptoms of Cushing disease, including abdominal striae and facial rounding, were more common among younger patients than older patients.

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications.The ...

Sky Force box office collection day 5: The aerial action drama is inching towards the ₹100-crore mark despite a drop in earnings during the midweek. Akshay Kumar and Veer Pahariya's Sky Force ...

Sinusitis can cause facial pressure, sinus headache, and other symptoms. Treatment may depend on the cause. A sinus infection, also known as sinusitis or rhinosinusitis, occurs when your nasal ...

Its etiology is common with that of clinical hypothyroidism; clinical symptoms most often include weight gain and fatigue. Subclinical forms of hypothyroidism are of increasing interest ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...